Production (Stage)
Disc Medicine, Inc.
IRON
$53.71
$1.001.90%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -116.49M | -109.36M | -103.48M | -91.00M | -80.60M |
Total Depreciation and Amortization | 150.00K | 156.00K | 172.00K | 186.00K | 101.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 12.01M | 12.04M | 10.21M | 9.70M | 8.91M |
Change in Net Operating Assets | 2.63M | 3.23M | 8.95M | 6.85M | -11.00K |
Cash from Operations | -101.70M | -93.93M | -84.15M | -74.26M | -71.60M |
Capital Expenditure | -1.29M | -505.00K | -59.00K | -112.00K | -127.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -563.61M | -291.83M | -290.85M | -219.75M | -- |
Cash from Investing | -564.90M | -292.33M | -290.91M | -219.86M | -127.00K |
Total Debt Issued | 28.99M | 28.99M | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 409.68M | 190.72M | 197.28M | 197.37M | 168.66M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 7.99M | -1.39M | 0.00 | -58.00K | 9.32M |
Cash from Financing | 446.67M | 218.31M | 197.28M | 197.31M | 177.97M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -219.94M | -167.94M | -177.78M | -96.82M | 106.25M |